INS and type 1 diabetes mellitus: Previously, oral insulin therapy at a modest daily dose of 7.5 mg did not delay progression to type 1 diabetes in first-degree relatives with insulin autoantibodies and ICA, except for a subgroup of relatives with high levels of insulin antibodies [49].